| Literature DB >> 32019511 |
Fengyao Wu1,2, Fengying Lu1,2, Xin Fan1,3, Jin Chao1,4, Chuanmin Liu1,2, Qunxing Pan1,2, Huawei Sun1,2, Xiaofei Zhang5,6.
Abstract
BACKGROUND: Duck hepatitis A virus type 3 (DHAV-3) is one of the most harmful pathogens in the duck industry. However, the molecular mechanism underlying DHAV-3 infection in ducklings remains poorly understood. To study the genetic regulatory network for miRNA-mRNA and the signaling pathways involved in DHAV-3 infection in ducklings, we conducted global miRNA and mRNA expression profiling of duckling liver tissues infected with lethal DHAV-3 by high-throughput sequencing.Entities:
Keywords: Duck hepatitis a virus type 3; Host-virus interactions; Innate immune response; Transcriptome; miRNA; miRNA-mRNA network
Mesh:
Substances:
Year: 2020 PMID: 32019511 PMCID: PMC7001231 DOI: 10.1186/s12864-020-6539-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Workflow of analyses and bioinformatic pipelines. a Pipeline for identification and analyses of miRNAs. b Pipeline for analyses of transcriptome sequencing data. c Pipeline for construction of immune-related miRNA-mRNA negative correlation network
Fig. 2Characterization of DHAV-3 infection in duckling liver. a Healthy duckling liver in the control group. b Duckling liver at 12 hpi began to have petechial hemorrhages. c Duckling liver at 24 hpi is typically enlarged with petechial hemorrhages throughout. d Liver of dead duckling at 36 hpi. e DHAV-3 replication in the duckling liver at 3, 12, 24 and 36 hpi. The data are expressed as mean ± standard deviation. Three samples were selected for detecting the viral RNA load using the TaqMan qRT-PCR method
Overview of small RNA sequencing in the mock-infected and DHAV-3-infected libraries
| Type | Mock-infected duck liver | DHAV-3-infected duck liver | ||||||
|---|---|---|---|---|---|---|---|---|
| Unique | Percent | Total | Percent | Unique | Percent | Total | Percent | |
| Raw reads | 11,826,502 | 14,689,775 | ||||||
| Clean reads | 139,965 | 9,172,408 | 240,697 | 9,531,577 | ||||
| rRNA | 17,855 | 12.76 | 275,818 | 3.01 | 35,351 | 14.69 | 2,301,404 | 24.15 |
| snRNA | 462 | 0.33 | 2910 | 0.03 | 1291 | 0.54 | 22,661 | 0.24 |
| snoRNA | 587 | 0.42 | 77,678 | 0.85 | 670 | 0.28 | 11,815 | 0.12 |
| tRNA | 5061 | 3.62 | 417,238 | 4.55 | 10,225 | 4.25 | 1,103,800 | 11.58 |
| exon_sense | 15,717 | 11.23 | 43,102 | 0.47 | 29,505 | 12.26 | 95,225 | 1.00 |
| exon_antisense | 408 | 0.29 | 1542 | 0.02 | 310 | 0.13 | 1949 | 0.02 |
| intron_sense | 5040 | 3.60 | 35,317 | 0.39 | 4684 | 1.95 | 35,333 | 0.37 |
| intron_antisense | 6238 | 4.46 | 60,363 | 0.66 | 14,173 | 5.89 | 1,323,996 | 13.89 |
| repeat | 444 | 0.32 | 84,834 | 0.92 | 487 | 0.20 | 282,012 | 2.96 |
| miRNA | 21,271 | 15.20 | 7,281,344 | 79.39 | 9365 | 3.89 | 1,050,011 | 11.02 |
| unannotated | 66,350 | 47.40 | 878,547 | 9.58 | 134,035 | 55.69 | 3,289,546 | 34.51 |
Fig. 3Summary of small RNA sequencing in the mock-infected and DHAV-3-infected duckling liver libraries. a Overview of small RNA sequence in the mock-infected and DHAV-3-infected libraries. b Length distributions of clean reads in the mock-infected and DHAV-3-infected libraries
Fig. 4Comparison of miRNA expression between the mock-infected and DHAV-3-infected libraries. a The scatter plot of differentially expressed miRNAs of DHAV-3-infected vs. mock-infected libraries. b Validation of DEMs by stem-loop quantitative RT-PCR. The relative expression level of each miRNA in DHAV-3-infected sample was calculated using the 2−ΔΔCt method and represented as an n-fold change compared to the mock-infected sample
Major characteristics of mRNA libraries and reads mapping to the duck reference genome
| Sample | Clean reads | Filter reads | Reads mapping to genome | |||
|---|---|---|---|---|---|---|
| Unique mapped reads | Mutiple mapped reads | Unmapped reads | Mapping ratio (%) | |||
| C1 | 71,247,742 | 68,240,188 | 51,250,772 | 258,906 | 16,730,510 | 75.48 |
| C2 | 55,513,732 | 53,236,588 | 39,110,688 | 254,606 | 13,871,294 | 73.94 |
| C3 | 66,268,876 | 63,854,884 | 47,976,494 | 280,978 | 15,597,412 | 75.57 |
| SD1 | 58,962,100 | 54,740,070 | 38,301,958 | 154,838 | 16,283,274 | 70.25 |
| SD2 | 56,170,156 | 52,753,656 | 36,074,767 | 138,914 | 16,539,975 | 68.65 |
| SD3 | 52,572,684 | 50,532,548 | 35,338,685 | 166,060 | 15,027,803 | 70.26 |
Fig. 5Comparison of gene expression between the mock-infected and DHAV-3-infected libraries. a The volcano plot of differentially expressed genes of DHAV-3-infected vs. mock-infected libraries. Red points represent up-regulated genes, green points represent down-regulated genes, and black points represent genes with no significant difference. b Validation of DEGs by qRT-PCR. The relative expression level of each gene in DHAV-3-infected sample was calculated using the 2−ΔΔCt method and represented as the n-fold change compared to the mock-infected sample
Fig. 6Functional enrichment analysis of genes in the negatively correlated miRNA-mRNA network. a The top 20 enriched GO biological processes of genes involved in the negative miRNA-mRNA network. The darker the color of the bar, the smaller the q-value. The numbers indicate the related gene number and the q-value of each GO term. b The top 20 enriched KEGG pathways of genes involved in the negative miRNA-mRNA network. The larger the dot, the greater the number of genes. The redder the color, the smaller the q-value
Fig. 7Immune-related miRNA-mRNA negative correlation network. The interaction network constructed on the basis of immune-related DEMs and DEGs of DHAV-3-infected vs. mock-infected comparisons. The miRNAs are displayed as green circles, and the target genes are shown as pink circles
Candidate immune-related miRNAs in the DHAV-3-infected duckling
| miRNA | Up down regulation | Candidate target gene | Pathway | |
|---|---|---|---|---|
| apl-miR-32-5p | Down | 4.40E-84 | RIG-I-like receptor signaling pathway | |
| RIG-I-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway | ||||
| Cytokine-cytokine receptor interaction; Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway; NOD-like receptor signaling pathway | ||||
| apl-miR-125-5p | Down | 5.18E-113 | RIG-I-like receptor signaling pathway | |
| RIG-I-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway | ||||
| apl-miR-128-3p | Down | 1.35E-128 | RIG-I-like receptor signaling pathway | |
| Toll-like receptor signaling pathway | ||||
| RIG-I-like receptor signaling pathway; Apoptosis | ||||
| Jak-STAT signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| Cytokine-cytokine receptor interaction; Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway; NOD-like receptor signaling pathway | ||||
| apl-miR-460-5p | Down | 2.39E-16 | RIG-I-like receptor signaling pathway | |
| RIG-I-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway | ||||
| Cytokine-cytokine receptor interaction; MAPK signaling pathway; Apoptosis; p53 signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway; NOD-like receptor signaling pathway; Apoptosis | ||||
| novel-m0012-3p | Down | 3.91E-02 | RIG-I-like receptor signaling pathway | |
| RIG-I-like receptor signaling pathway; MAPK signaling pathway | ||||
| Toll-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway | ||||
| Toll-like receptor signaling pathway; RIG-I-like receptor signaling pathway; NOD-like receptor signaling pathway; Apoptosis; p53 signaling pathway |